A Qualitative Exploration in Pancreatic Neuroendocrine Tumour Patients

• Research type

  Research Study

• Full title

  A Qualitative Exploration into the Experience of Neuroendocrine Pancreatic Cancer Patients Receiving Molecular Targeted Therapies (Sunitinib Malate or Everolimus)

• IRAS ID

  124673

• Contact name

  Jacquie Woodcock

• Contact email

  jacquie.woodcock@rmh.nhs.uk

• Sponsor organisation

  St Georges University of London

• Research summary

  The principle aim of this study is to evaluate the lived experience of pancreatic neuroendocrine cancer patients receiving molecular targeted therapies used in this condition (Sunitanib Malate and Everolimus.) A qualitative method will be used, exploring this complex multifaceted experience. A phenomenological line of enquiry it to be used in the form of unstructured patient interviews. Patients receiving an oral anti-cancer agent at home are required to balance this with their other roles, functions, thoughts and feelings around this treatment. Phenomenology examines practical issues within the lived experience of a particular experience, rendering it ideal for this project.

• REC name

  London - Queen Square Research Ethics Committee

• REC reference

  14/LO/0296

• Date of REC Opinion

  11 Mar 2014

• REC opinion

  Further Information Favourable Opinion